Key facts
- iotaSciences’s last known valuation is $4.5M.
- It has raised $14.4M; the latest was Later Stage VC ($2.6M) in Jul 2024.
- Notable investors include Future Planet Capital, University of Oxford, Oxford Science Enterprises, Oxford Innovation Finance, Oxford Investment Consultants — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for iotaSciences
- ·The full record, as it builds
Funding rounds
No funding rounds for iotaSciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About iotaSciences
Developer of a fluid-shaping technology designed to accelerate and simplify single-cell cloning. The company's technology replaces microtiter plates with single-cell cloning by harnessing the power and benefits of microscale fluid-shaping in exposing cells to relevant and translational experimental conditions, enabling researchers to conduct several experiments from multiple users simultaneously with ease.
- Sector
- Healthcare
- HQ
- Oxford, United Kingdom
- Founded
- 2016
- Employees
- 14
- Website
- iotasciences.com/
- Ownership
- Privately Held (backing)
iotaSciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in iotaSciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on iotaSciences in its N-PORT filings yet. We sweep new filings monthly.